Development and Validation of a Novel Nomogram for Predicting Tumor-Distant-Metastasis in Patients with Early T1-2 Stage Lung Adenocarcinoma

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics 2019. CA Cancer J Clin. 2019;69(1):7–34.
   PubMed Web of Science ®Google Scholar
• Nakazawa K, Kurishima K, Tamura T, et al. Specific organ metastasis and survival in small cell lung cancer. Oncol Lett. 2012;4:617–620. doi:10.3892/ol.2012.792
   PubMed Web of Science ®Google Scholar
• Riihimaki M, Hemminki A, Fallah M, et al. Metastatic sites and survival in lung cancer. Lung Cancer. 2014;86:78–84. doi:10.1016/j.lungcan.2014.07.020
   PubMed Web of Science ®Google Scholar
• Tamura T, Kurishima K, Nakazawa K, et al. Specific organ metastases and survival in metastatic non-small-cell lung cancer. Mol Clin Oncol. 2015;3(1):217–221. doi:10.3892/mco.2014.410
   PubMedGoogle Scholar
• Ashour Badawy A, Khedr G, Omar A, et al. Site of metastases as prognostic factors in unselected population of stage IV non-small cell lung cancer. Asian Pac J Cancer Prev. 2018;19(7):1907–1910.
   PubMedGoogle Scholar
• Goldstraw P, Chansky K, Crowley J, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11:39–51.
   PubMed Web of Science ®Google Scholar
• Chen Y-H, Chen Y-F, Chen C-Y, et al. Clinical factors associated with treatment outcomes in EGFR mutant non-small cell lung cancer patients with brain metastases: a case-control observational study. BMC Cancer. 2019;19(1):1006. doi:10.1186/s12885-019-6140-0
   PubMed Web of Science ®Google Scholar
• Yang Q, Zhang P, Wu R, et al. Identifying the best biomarker combination in CEA, CA125, CY211, NSE, and SCC for lung cancer screening by combining ROC curve and logistic regression analyses: is it feasible? Dis Biomarkers. 2018;2018:1–12.
   Google Scholar
• Kudo Y, Haymaker C, Zhang J, et al. Suppressed immune microenvironment and repertoire in brain metastasis from patients with resected non-small cell lung cancer. Ann Oncol. 2019;30(9):1521–1530. doi:10.1093/annonc/mdz207
   PubMed Web of Science ®Google Scholar
• Darlix A, Lamy PJ, Lopez-Crapez E, et al. Serum NSE, MMP-9 and HER2 extracellular domain are associated with brain metastasis in metastatic breast cancer patients: predictive biomarkers for brain metastasis? Int J Cancer. 2016;139(10):2299–2311.
   PubMed Web of Science ®Google Scholar
• Wang J, Chu Y, Li J, et al. The clinical value of carcinoembryonic antigen for tumor metastasis assessment in lung cancer. PeerJ. 2019;7:e7433. doi:10.7717/peerj.7433
   PubMed Web of Science ®Google Scholar
• De Raaf PJ, Sleijfer S, Lamers CH, et al. Inflammation and fatigue dimensions in advanced cancer patients and cancer survivors: an explorative study. Cancer. 2012;118(23):6005–6011.
   PubMed Web of Science ®Google Scholar
• Li MM, Wang X, Yun ZY, et al. Platelet indices in non-small cell lung cancer patients with brain metastasis [J]. Cancer Biobiomarker. 2019;24(4):515–519. doi:10.3233/CBM-192393
   PubMed Web of Science ®Google Scholar
• Li H, Wang G, Zhang H, et al. Prognostic role of the systemic immune-inflammation index in brain metastases from lung adenocarcinoma with different EGFR mutations. Genes Immun. 2019;20(6):455–461. doi:10.1038/s41435-018-0050-z
   PubMed Web of Science ®Google Scholar
• Weichselbaum RR, Hellman S. Oligometastases revisited. Nat Rev Clin Oncol. 2011;8(6):378–382. doi:10.1038/nrclinonc.2011.44
   PubMed Web of Science ®Google Scholar
• Wu Y, Liu J, Han C, et al. Preoperative prediction of lymph node metastasis in patients with early-T-stage non-small cell lung cancer by machine learning algorithms. Front Oncol. 2020;10:743.
   PubMed Web of Science ®Google Scholar
• Rami-Porta R, Bolejack V, Crowley J, et al. The IASLC lung cancer staging project: proposals for the revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for lung cancer. J Thorac Oncol. 2015;10(7):990–1003.
   PubMed Web of Science ®Google Scholar
• Takenaka T, Takenoyama M, Yamaguchi M, et al. Impact of the epidermal growth factor receptor mutation status on the post-recurrence survival of patients with surgically resected non–small-·cell lung cancer. Eur J Cardiothorac Surg. 2015;47(3):550–555. doi:10.1093/ejcts/ezu227
   PubMed Web of Science ®Google Scholar
• Liao Y, Yin G, Fan X. The positive lymph node ratio predicts survival in T1-4N1-3M0 non-small cell lung cancer: a nomogram using the SEER database. Front Oncol. 2020;10:1356. doi:10.3389/fonc.2020.01356
   PubMed Web of Science ®Google Scholar
• Wo Y, Yang H, Zhang Y, et al. Development and external validation of a nomogram for predicting survival in patients with stage IA non-small cell lung cancer ≤2 cm undergoing sublobectomy. Front Oncol. 2019;9:1385. doi:10.3389/fonc.2019.01385
   PubMed Web of Science ®Google Scholar
• Kang J, Ning MS, Feng H, et al. Predicting 5-year progression and survival outcomes for early stage non-small cell lung cancer treated with stereotactic ablative radiation therapy: development and validation of robust prognostic nomograms. Int J Radiat Oncol Biol Phys. 2020;106(1):90‐99. doi:10.1016/j.ijrobp.2019.09.037
   Web of Science ®Google Scholar
• Zhang J, Gold KA, Lin HY, et al. Relationship between tumor size and survival in non-small-cell lung cancer (NSCLC): an analysis of the surveillance, epidemiology, and end results (SEER) registry. J Thorac Oncol. 2015;10(4):682‐690. doi:10.1097/JTO.0000000000000456
   Web of Science ®Google Scholar
• Cacho-Díaz B, Spínola-Maroño H, Mendoza-Olivas LG, et al. Association of neurologic manifestations and CEA levels with the diagnosis of brain metastasis in lung cancer patients. Clin Transl Oncol. 2019;21(11):1538–1542. doi:10.1007/s12094-019-02086-y
   PubMed Web of Science ®Google Scholar
• Ayan AK, Erdemci B, Orsal E, et al. Is there any correlation between levels of serum ostepontin, CEA, and FDG uptake in lung cancer patients with bone metastasis? Rev Esp Med Nucl Imagen Mol. 2016;35(2):102‐106.
   PubMed Web of Science ®Google Scholar
• Li B, Yuan Q, Zou YT, et al. CA-125, CA-153, and CYFRA21-1 as clinical indicators in male lung cancer with ocular metastasis. J Cancer. 2020;11(10):2730‐2736.
   Web of Science ®Google Scholar
• Zhang X, Guo M, Fan J, et al. Prognostic significance of serum LDH in small cell lung cancer: a systematic review with meta-analysis. Cancer Biomark. 2016;16(3):415–423. doi:10.3233/CBM-160580
   PubMed Web of Science ®Google Scholar
• Deng T, Zhang J, Meng Y, et al. Higher pretreatment lactate dehydrogenase concentration predicts worse overall survival in patients with lung cancer. Medicine (Baltimore). 2018;97(38):e12524.
   PubMed Web of Science ®Google Scholar
• Lee DS, Park KR, Kim SJ, et al. Serum lactate dehydrogenase levels at presentation in stage IV non-small cell lung cancer: predictive value of metastasis and relation to survival outcomes. Tumour Biol. 2016;37(1):619–625. doi:10.1007/s13277-015-3776-5
   PubMedGoogle Scholar
• de Jong C, Deneer VHM, Kelder JC, et al. Association between serum biomarkers CEA and LDH and response in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Thorac Cancer. 2020;11(7):1790–1800. doi:10.1111/1759-7714.13449
   PubMed Web of Science ®Google Scholar
• Dong T, Liu Z, Xuan Q, et al. Tumor LDH-A expression and serum LDH status are two metabolic predictors for triple negative breast cancer brain metastasis. Sci Rep. 2017;7(1):6069. doi:10.1038/s41598-017-06378-7
   PubMed Web of Science ®Google Scholar
• Baniyash M. Myeloid-derived suppressor cells as intruders and targets: clinical implications in cancer therapy. Cancer Immunol Immunother. 2016;65(7):857–867. doi:10.1007/s00262-016-1849-y
   PubMed Web of Science ®Google Scholar
• Yang LY, Wu XJ, Ye SB, et al. Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer. J Transl Med. 2015;13(47):1–12.
   PubMedGoogle Scholar
• Kedzierska M, Czernek U, Szydowska-Pazera K, et al. The changes of blood platelet activation in breast cancer patients before surgery, after surgery, and in various phases of the chemotherapy. Platelets. 2013;24(6):462–468.
   PubMed Web of Science ®Google Scholar
• Amaral SR, Casal Moura M, Carvalho J, et al. Prognostic significance of neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors. Ann Oncol. 2019;30(1):i3.
   Google Scholar
• Koh YW, Choi JH, Ahn MS, et al. Base line neutrophil-lympho- cyte ratio is associated with baseline and subsequent presence of brain metastasis in advanced non-small-cell lung cancer. Sci Rep. 2016;6(1):38585. doi:10.1038/srep38585
   PubMed Web of Science ®Google Scholar
• Montfort A, Pearce O, Maniati E, et al. A strong B-cell response is part of the immune landscape in human high-grade serous ovarian metastases. Clin Cancer Res. 2017;23(1):250–262. doi:10.1158/1078-0432
   PubMed Web of Science ®Google Scholar
• DiLillo DJ, Yanaba K, Tedder TF. B cells are required for optimal CD4+ and CD8+ T cell tumor immunity: therapeutic B cell depletion enhances B16 melanoma growth in mice. J Immunol. 2010;184(7):4006–4016. doi:10.4049/jimmunol.0903009
   PubMed Web of Science ®Google Scholar
• Brambilla E, Le Teuff G, Marguet S, et al. Prognostic effect of tumor lymphocytic infiltration in resectable non-small-cell lung cancer. J Clin Oncol. 2016;34(11):1223–1230. doi:10.1200/JCO.2015.63.0970
   PubMed Web of Science ®Google Scholar
• Imahayashi S, Ichiyoshi Y, Yoshino I, et al. Tumor-infiltrating B-cell-derived IgG recognizes tumor components in human lung cancer. Cancer Invest. 2000;18(6):530–536.
   PubMed Web of Science ®Google Scholar
• Liu J, Yang X, Lu X, et al. Impact of T-cell receptor and B-cell receptor repertoire on the recurrence of early stage lung adenocarcinoma. Exp Cell Res. 2020:112134.
   PubMed Web of Science ®Google Scholar